Hello, Fool! | Login | Signup | My Fool
Aug 30, 2008 7:22 AM ET | Site Changes | Help
The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies.
View Ticker Page (BIIB)
Results 21 - 30 of 76 : 12345Next »
Recs
shoprat1 (45.48) Submitted: 3/12/08 12:35 PM : Start Price: $59.42 BIIB Score: -11.19
goog biotech at a bargin
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
pilarcity (63.92) Submitted: 1/11/08 6:02 AM : Start Price: $59.33 BIIB Score: -5.64
The growing sales of Tysabri and an excellent R&D pipeline is their competitive edge in the market.Recently they were "invited" by Mr Icahn, but they continue independent. The price raised to $80, and now is in $60...
TMFBreakerJava (99.33) Submitted: 3/06/08 10:52 AM : Start Price: $59.28 BIIB Score: -11.35
They have taken themselves off the market and the price has pulled back. Tysabri sales continue to ramp and a number of price moving events are coming up this year. I expect that the price will be meaningfully higher by the end of the year.
Tyren22 (< 20) Submitted: 1/17/08 5:20 PM : Start Price: $60.14 BIIB Score: -6.36
MS drug Tysabri also approved for use in treating Crohn's Disease.
caseykimma (89.28) Submitted: 2/03/08 4:30 PM : Start Price: $62.06 BIIB Score: -10.45
This company has the resources and $$ for the long haul and bounces back every time.
slade15342 (96.49) Submitted: 2/24/08 11:16 AM : Start Price: $60.30 BIIB Score: -10.56
Biogen is on a rampage over the course of this stocks inception in the arly 1980s. A slow roller at first like most biotechnology corporations that pour their heart and wallet into R&D, this company now has several legit drugs. And with the acquisi...
LeBella (29.61) Submitted: 3/14/08 4:15 PM : Start Price: $60.33 BIIB Score: -15.14
Biotech firm, medical good investment
Report this Post Replies: 1 | Reply | Permalink
SuperStocker1 (< 20) Submitted: 8/14/08 9:25 PM : Start Price: $54.86 BIIB Score: -6.28
Recovery breakout upwards
glennwhiteside (< 20) Submitted: 8/11/08 2:10 AM : Start Price: $50.35 BIIB Score: 1.69
overreaction
addaam78 (83.27) Submitted: 8/08/08 4:19 PM : Start Price: $50.35 BIIB Score: 1.69
Great, innovative company with earnings and revenue growth. It markets 4 drugs at the moment and has lost some 20% in a few days due to the Tysabri scare.It is a possible takeover target and if the drug is not pulled out of the market it ...
Terms & Conditions
RSS Headlines
Fool UK